Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer
1998

Effects of Castration Therapy on Prostate Cancer

Sample size: 28 publication Evidence: moderate

Author Information

Author(s): P Stattin, P Westin, J-E Damber, A Bergh

Primary Institution: Umeå University, Umeå, Sweden

Hypothesis

Can short-term effects of castration therapy predict clinical response in prostate cancer patients?

Conclusion

Castration therapy induces morphological changes and increases the apoptotic index in responding prostate tumors, which may help predict clinical outcomes.

Supporting Evidence

  • 14 out of 15 responding tumors showed regressive changes after therapy.
  • The median apoptotic index increased from 2.6 to 3.5 among responders.
  • Median bcl-2 index increased from 1.5 to 10.0 in responders after therapy.
  • Only 4 out of 13 non-responders showed regressive morphology after therapy.

Takeaway

When doctors give castration therapy to prostate cancer patients, they can look at the tumor cells to see if the treatment is working just a week later.

Methodology

Biopsies were taken from patients before and after castration therapy, and various cellular effects were assessed.

Limitations

The study had a small sample size and limited tissue from patients, which may affect the results.

Participant Demographics

Patients aged 74-85 years with advanced prostate cancer.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication